Testing effectiveness (Phase 2)Study completedNCT01678898What this trial is testingDose-ranging Study of PRX-102 in Adult Fabry Disease PatientsWho this might be right forFabry Disease Protalix 18
Not applicableUnknownNCT01126775What this trial is testingNeuro-Prävention im Rahmen Des Interventionsprojektes INVADE-2 (Follow-up Studie)Who this might be right forStrokeDementia INVADE gGmbH 1,000
Not applicableLooking for participantsNCT04962295What this trial is testingChina Imaging-based Biobank of Cerebral Small Vessal DiseasesWho this might be right forCerebral Small Vessel Diseases Peking University Third Hospital 10,000
Not applicableStudy completedNCT05495607What this trial is testingContinous Renal Replacement Therapy With the CARPEDIEM® in a French National Cohort of 25 Neonates and Small InfantsWho this might be right forHypoxic-Ischemic EncephalopathySepsisKidney Diseases+4 more Centre Hospitalier Universitaire de Nice 25
Not applicableNot Yet RecruitingNCT07650110What this trial is testingBiological Collection of the Rare Diseases of the Brain and Eye Vessels Cohort - 2Who this might be right forCADASILCavernous AngiomaCerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy+1 more Assistance Publique - Hôpitaux de Paris 600
Not applicableStudy completedNCT07136662What this trial is testingAnderson Fabry Disease - the Power of Information.Who this might be right forFabry Disease Fondazione Policlinico Universitario Agostino Gemelli IRCCS 20
Not applicableEnded earlyNCT04999059What this trial is testingLong-Term Follow-up Study of Subjects With Fabry Disease Who Received Lentiviral Gene Therapy in Study AVRO-RD-01-201Who this might be right forFabry Disease AVROBIO 5
Not applicableStudy completedNCT03135197What this trial is testingGerman Observational Multicenter Study of Patients With Fabry Disease Under Chaperone Therapy With Migalastat-HCl.Who this might be right forFabry Disease University Hospital Muenster 75
Large-scale testing (Phase 3)Study completedNCT03018730What this trial is testingSafety and Efficacy of PRX-102 in Patients With Fabry Disease Currently Treated With REPLAGAL® (Agalsidase Alfa)Who this might be right forFabry Disease Protalix 22
Not applicableStudy completedNCT02210130What this trial is testingThe Microvascular Brain Retina And Kidney StudyWho this might be right forCerebral Small Vessels Disease Fondation Ophtalmologique Adolphe de Rothschild 163
Not applicableStudy completedNCT04529642What this trial is testingIs the 6-Minute Walking Test Combined With an IMU Useful in Stroke Rehabilitation Assessment?Who this might be right forStrokePhysical Therapy ModalitiesGait Analysis Fondazione Don Carlo Gnocchi ETS 46
Not applicableLooking for participantsNCT04310098What this trial is testingCADASIL Registry StudyWho this might be right forCadasil Bin Cai 1,000
Not applicableEnded earlyNCT05699265What this trial is testingCardiovasculorenal Phenotyping in Fabry Disease Through Noninvasive TestingWho this might be right forFabry Disease Children's Hospital Medical Center, Cincinnati 4
Testing effectiveness (Phase 2)Study completedNCT02489344What this trial is testingEvaluation of the Long-term Safety, Pharmacodynamics, and Exploratory Efficacy of GZ/SAR402671 in Treatment-Naïve Adult Male Patients With Fabry DiseaseWho this might be right forFabry Disease Genzyme, a Sanofi Company 8
Not applicableActive Not RecruitingNCT05039866What this trial is testingLong-Term Follow-up of Subjects Who Were Treated With ST-920Who this might be right forFabry DiseaseFabry Disease, Cardiac Variant Sangamo Therapeutics 32
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07692399What this trial is testingSafety and Efficacy of Edaravone Dexborneol Sublingual Tablets for Blood-Brain Barrier Dysfunction in CADASILWho this might be right forCADASIL Huashan Hospital 60